Skip to main content

This job has expired

You will need to login before you can apply for a job.

(Senior) Vice President, Investor Relations & Corporate Communications

Employer
Intellia Therapeutics
Location
Cambridge, MA, United States
Start date
Feb 23, 2021

View more

Discipline
Marketing, Marketing/Corporate Communications
Required Education
Bachelors Degree
Position Type
Full time
Hotbed
Genetown

Job Details

Our Mission: Developing curative genome editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.

At Intellia, we are committed to solving the complex challenges of making CRISPR/Cas9-based medicines a reality for patients suffering from genetic diseases and to create novel engineered cell therapies for immuno-oncological and autoimmune diseases.

Job Description:

Intellia Therapeutics is growing and we are in search of a dynamic Vice President or Senior Vice President to lead and provide oversight of Investor Relations & Corporate Communications at the company.

This individual will report to the Chief Financial Officer and work closely with the executive team to establish and implement a successful Investor Relations strategy that articulates and supports the Company's business and scientific objectives to the investment community and other external audiences including the scientific community. He/she will also manage all external communications, scientific communications and public affairs, including media and public relations (news and editorial coverage, white papers, press releases and articles); financial communications, strategic executive communications; crisis communications; and Company website communications. Will act as a Company spokesperson, promoting, enhancing, and projecting the organization's vision, brand and reputation to external stakeholders, with a primary focus on analysts and investors, and build new and manage existing relationships with the investment community and other outside influencers.

RESPONSIBILITES:
  • Design and implement an investor relations program to ensure a consistent, timely flow of information about Intellia to the investment communities and Company shareholders. Establish and maintain excellent relations with institutional investors, key retail investors and analysts
  • Understand the technology, pipeline and business strategy sufficiently to identify issues and effectively communicate with investors
  • Partner with the CEO and CFO to lead and manage the Company's participation on quarterly earnings calls, investment conference calls and in-house meetings, road shows, analyst days, and one-on-one meetings
  • Develop relationships and maintain regular communication with individual investors, covering analysts and select buy-side contacts to provide up to date information about events and market trends affecting the Company, with the goal of communicating our long-term vision
  • Manage the Company's corporate communications via the website, social media channels, etc. Update and continuously improve the corporate website and social media efforts ensuring that key messages and communications are consistent
  • Lead strategic communications development, including, developing communications plan to take advantage of key Company milestones, preparing press releases, presentation decks, and earnings releases, creating management Q&As, conference call scripts, and business descriptions/other information for securities filings, and the Company website
  • Serve as a primary person to handle incoming inquiries from the media and investors
  • Establish strong internal relationships and effective communication with supporting business, scientific, and medical leadership within the organization
  • Manage an internal team along with an external set of advisors to successfully meet group objectives


QUALIFICATIONS:
  • Bachelor's degree required; MBA preferred
  • 10+ years of professional level experience with a minimum of 8 years of experience in investor relations, corporate communications, and related areas
  • A minimum of 5 years of investor relations experience in the biotech/pharmaceutical industry speaking and presenting to investors and analysts
  • Proven ability to hire top talent and build high performing teams
  • Demonstrated experience and leadership in managing a comprehensive strategic communications programs to advance the organizations vision, mission, values, and strategic objectives
  • Experience in delivering clear consistent messaging of scientific and clinical concepts across multiple stakeholders / audiences
  • Proven track record of developing a positive, long-term relationship with the investment community
  • Experience with, and a working knowledge of SEC disclosure requirements, shareholder/analyst communications practices, and preparing investor presentations and events
  • Demonstrated experience to lead and influence within a matrixed environment, including with senior management
  • Experience in managing and overseeing contract IR/PR agencies and vendors
  • Computer skills are a must (particularly PowerPoint, Excel and Word)


EEOC Statement: Intellia believes in a diverse environment, and is committed to equal employment opportunity for all its employees and qualified applicants. We do not discriminate in recruitment, hiring, training, promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status. Intellia will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.

Company

Many of us pursuing work in the biotechnology industry are inspired by a loved one who is living with a disease or the loss of someone in our community. Rare genetic and oncological and immunological diseases not only affect the people living with often debilitating and life-threatening symptoms, but these disorders also significantly impact their families, friends and caregivers.
 
Our researchers work tirelessly to harness the genome editing technology CRISPR/Cas9 for human therapeutic use. Jennifer Doudna, an Intellia co-founder, and Emmanuelle Charpentier were awarded the 2020 Nobel Prize in Chemistry for their pioneering work in CRISPR. We at Intellia are humbled to have a hand in making what we believe to be medical history. As a leader in this space, we take this responsibility to patients seriously.
 
We are employing a modular genome editing platform to create diverse in vivo and ex vivo pipelines, spanning a range of therapeutic indications. Guided by this full-spectrum approach, we are committed to making CRISPR/Cas9-based medicines a reality for patients suffering from genetic diseases and to creating novel engineered cell therapies for various cancers and autoimmune diseases.

Change life stories with genome editing therapies!

Stock Symbol: NTLA

TwitterInstagram

Company info
Website
Phone
(857) 285-6200
Location
40 Erie Street
Cambridge
Massachusetts
02139
United States

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert